RFX6 and neoplasm: Subcutaneous models revealed that silencing PGAM1 suppressed the RFX6‐induced cell proliferation in vivo, presenting as attenuated tumour volumes, tumour weights and Ki67+ cells in the stable PGAM1‐KD groups (Figure 6I,J).